Literature DB >> 26382897

Angiographic and In Vivo Confocal Microscopic Characterization of Human Corneal Blood and Presumed Lymphatic Neovascularization: A Pilot Study.

Vito Romano1, Bernhard Steger, Yalin Zheng, Sajjad Ahmad, Colin E Willoughby, Stephen B Kaye.   

Abstract

PURPOSE: To characterize corneal nevocoarization (CoNV) in vivo.
METHODS: Patients with CoNV were categorized into those with active disease defined by the presence of corneal infiltrates and/or edema and those with inactive disease, the latter divided into those with or without corneal red blood cell traffic (RBCT). CoNV were imaged using in vivo confocal microscopy (IVCM) and angiography. Leakage and uptake of dye from the extravascular to intravascular space were investigated using repeat angiography and digital subtraction analysis. Vessel parameters and the presence of RBCT were analyzed using custom-designed software.
RESULTS: Thirteen patients with CoNV were included: 4 had active and 9 had inactive disease with CoNV present for 3.5 ± 1.7 months and 30.2 ± 30.7 months, respectively. Using a combination of digital subtraction analysis and IVCM, presumed lymphatic vessels were detected only in patients with active CoNV. These vessels were characterized by an indistinct vessel wall, carrying nucleated cells, and on IVCM, it had a mean diameter of 19.7 ± 6.1 μm (11-30 μm). The ratio of the diameter of presumed lymphatic vessels to that of neighboring vessels was 0.6 ± 0.1 (0.5-0.6). Of the patients with inactive disease, 4 had CoNV with RBCT (mean age CoNV, 17.3 ± 7.6 months) and 5 (mean age CoNV, 40.6 ± 35 months) had CoNV without evidence of RBCT on biomicroscopy, but evident on angiography and IVCM. These represent perfused vessels with no or intermittent RBCT.
CONCLUSIONS: CoNV can be characterized in vivo using a combination of IVCM and angiography. The vascular features vary according to the age of the CoNV and disease activity. Further improvements in angiographic image alignment, however, are needed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26382897     DOI: 10.1097/ICO.0000000000000609

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

1.  Organogenesis and distribution of the ocular lymphatic vessels in the anterior eye.

Authors:  Yifan Wu; Young Jin Seong; Kin Li; Dongwon Choi; Eunkyung Park; George H Daghlian; Eunson Jung; Khoa Bui; Luping Zhao; Shrimika Madhavan; Saren Daghlian; Patill Daghlian; Desmond Chin; Il-Taeg Cho; Alex K Wong; Martin Heur; Sandy Zhang-Nunes; James C Tan; Masatsugu Ema; Tina T Wong; Alex S Huang; Young-Kwon Hong
Journal:  JCI Insight       Date:  2020-07-09

Review 2.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

3.  Comparison of Optical Coherence Tomography Angiography to Indocyanine Green Angiography and Slit Lamp Photography for Corneal Vascularization in an Animal Model.

Authors:  Tisha P Stanzel; Kavya Devarajan; Nyein C Lwin; Gary H Yam; Leopold Schmetterer; Jodhbir S Mehta; Marcus Ang
Journal:  Sci Rep       Date:  2018-07-31       Impact factor: 4.379

4.  Functional Staging of Corneal Neovascularization Using Fluorescein and Indocyanine Green Angiography.

Authors:  Christoph Palme; Vito Romano; Matthias Brunner; Riccardo Vinciguerra; Stephen B Kaye; Bernhard Steger
Journal:  Transl Vis Sci Technol       Date:  2018-10-01       Impact factor: 3.283

5.  Supplemental Anti Vegf A-Therapy Prevents Rebound Neovascularisation After Fine Needle Diathermy Treatment to Regress Pathological Corneal (LYMPH)Angiogenesis.

Authors:  Viet Nhat Hung Le; Yanhong Hou; Felix Bock; Claus Cursiefen
Journal:  Sci Rep       Date:  2020-03-03       Impact factor: 4.379

Review 6.  Retinal and Corneal Changes Associated with Intraocular Silicone Oil Tamponade.

Authors:  Mariantonia Ferrara; Giulia Coco; Tania Sorrentino; Kirti M Jasani; George Moussa; Francesco Morescalchi; Felipe Dhawahir-Scala; Francesco Semeraro; David H W Steel; Vito Romano; Mario R Romano
Journal:  J Clin Med       Date:  2022-09-05       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.